Canada’s Drug Pricing Reform Faces Legal Challenge
Canada’s R&D drug industry says it approached the court as a “necessary step,” given the significant impact of the pricing reforms.
Canada’s R&D drug industry says it approached the court as a “necessary step,” given the significant impact of the pricing reforms.